Activity of Compounds Isolated From Chilean Lichens Against Experimental Cutaneous Leishmaniasis
Comparative Biochemistry and Physiology Part C: Pharmacology, Toxicology and Endocrinology - Tập 116 - Trang 51-54 - 1997
Tài liệu tham khảo
Al-Bekairi, 1991, Mitodepressive, clastogenic and biochemical effects of (+) usnic acid in mice, J. Ethnopharmacol., 33, 217, 10.1016/0378-8741(91)90079-S
Berman, 1988, Chemotherapy for leishmaniasis, Rev. Infect. Dis., 10, 560, 10.1093/clinids/10.3.560
Buffet, 1995, Culture microtitration, Antimicrob. Agents Chemother., 39, 2167, 10.1128/AAC.39.9.2167
Chamy, 1985, Studies on Chilean lichens. VII. The phenolic constituents of Protousnea malacea, J. Nat. Prod., 48, 307, 10.1021/np50038a018
Croft, 1988, Recent developments in the chemotherapy of leishmaniasis, Trends Pharmacol. Sci., 9, 376, 10.1016/0165-6147(88)90258-1
Diaz, 1988, Actividad antibacteriana in vitro de la depsidona clorada 1′-cloropanarina, Rev. Lat. Am. Microbiol., 30, 79
Fournet, 1994, Leishmanicidal and trypanocidal activities of Bolivian medicinal plants, J. Ethnopharmacol., 41, 19, 10.1016/0378-8741(94)90054-X
Lauterwein, 1995, In vitro activities of the lichen secondary metabolites vulpinic acid, (+)-usnic acid, and (−)-usnic acid against aerobic and anaerobic microorganisms, Antimicrob. Agents Chemother., 39, 2541, 10.1128/AAC.39.11.2541
Möse, 1955, Zur antibakteriellen wirksamkeit der Usninsaüre, Arzneim. Forsch., 5, 510
Quilhot, 1992, Nuevos aportes en la investigación de metabolitos liquénicos, Dominguezia, 10, 7
Quilhot, 1989, Studies on Chilean lichens. XI. Secondary metabolites from Antarctic lichens, Ser. Cient. INACH, 39, 75
Stauber, 1958, An eight-day method for screening compounds against Leishmania donovani in Golden hamster, J. Protozool., 5, 269, 10.1111/j.1550-7408.1958.tb02565.x
Takai, 1979, Usnic acid derivatives as potential antineoplastic agents, J. Med. Chem., 22, 1380, 10.1021/jm00197a019
Yamamoto, 1995, Screening of tissue culture and thalli of lichens and some of their active constituents fro inhibition of tumor promoter-induced Epstein-Barr, Chem. Pharmacol. Bull., 43, 1388, 10.1248/cpb.43.1388